Source: Eur Respir Monogr 2021; 94: 28-38



Rating:

Share or cite this content

Citations should be made in the following way:
David S. Hui, Alimuddin Zumla. Historical perspective: other human coronavirus infectious diseases, SARS and MERS. Eur Respir Monogr 2021; 94: 28-38

Member's Comments

No comment yet.

Related content which might interest you: Update on respiratory virus research and clinical care including influenza outbreak 2017-18, SARS, MERS and other respiratory pathogens Source: International Congress 2018 – PG3 How to plan for and manage a respiratory epidemic/pandemic Year: 2018 Coronavirus disease: outbreak in China and globally Source: Webinar 2020 Year: 2020 Update on management of new emerging acute respiratory viral infectious diseases Source: International Congress 2018 – Chinese Programme 2018: Part I Year: 2018 Interview on Coronavirus COVID-19 management experience in China Source: Webinar 2020: Interview on Coronavirus COVID-19 management experience in China Year: 2020 Perspectives of the management of COVID-19 infection in China Source: Webinar 2020: Perspectives of the management of COVID-19 infection in China Year: 2020 Effects of allergic diseases on SARS-CoV-2 infection: Chinese and European perspectives Source: ERS webinar 2020: Effects of allergic diseases on SARS-CoV-2 infection: Chinese and European perspectives Year: 2020 Middle East respiratory syndrome coronavirus: epidemic potential or a storm in a teacup? Source: Eur Respir J 2014; 43: 1243-1248 Year: 2014 ERS/ATS joint webinar: Rehabilitation after COVID 19 disease Source: ERS webinar 2020: ERS/ATS joint webinar: Rehabilitation after COVID 19 disease Year: 2020 RSV and human metapneumovirus – major pathogens of childhood – also adults and the elderly? Source: Annual Congress 2005 - Major viral threats to the lung Year: 2005 ERS/ATS joint webinar on rehabilitation after COVID 19 disease: Q&A on Assessment Source: ERS webinar 2020: ERS/ATS joint webinar on rehabilitation after COVID 19 disease: Q&A on Assessment Year: 2020 Avian influenza and SARS – how much of a threat is it to humans and what can be done to prevent this? Source: Annual Congress 2005 - Major viral threats to the lung Year: 2005 Management of respiratory diseases in the COVID-19 pandemic Source: COVID-19 Videos Year: 2020 ERS/ATS joint webinar on rehabilitation after COVID 19 disease: Q&A on Programme Source: ERS webinar 2020: ERS/ATS joint webinar on rehabilitation after COVID 19 disease: Q&A on Programme Year: 2020 Features of the clinical course of coronavirus and bacterial pneumonia Source: Virtual Congress 2021 – COVID - 19 epidemiology Year: 2021 MERS-COV, SARS and related respiratory pathogens Source: ERS Course 2017 - Acute respiratory pandemics: how to plan for and manage Year: 2017 Infectious respiratory diseases: what vaccines can do Source: International Congress 2019 – The future of respiratory diseases: what prevention can do Year: 2019 Infantile respiratory syncytial virus and human rhinovirus infections: respective role in inception and persistence of wheezing Source: Eur Respir J 2015; 45: 774-789 Year: 2015 Emerging and re-emerging infectious diseases: a continuous challenge for Europe Source: Eur Respir J 2012; 40: 1312-1314 Year: 2012 Acute chikungunya virus infection and asthma Source: Eur Respir J 2010; 35: 1407-1409 Year: 2010